Medicine for treating leukemia

A leukemia and drug technology, applied in drug combinations, antineoplastic drugs, pharmaceutical formulations, etc., can solve problems such as damage to the gastrointestinal mucosa, decreased immunity, and many side effects

Inactive Publication Date: 2008-04-30
时竹明
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, Western medicine chemotherapy drugs have too many side effects, such as killing and inhibiting normal hematopoietic cells, leading to anemia and bleeding; inhibiting normal immune function, reducing the body's immunity, and easily merging with various infections; damaging the gastrointestinal mucosa, leading to anorexia, nausea, and vomiting ; Affect the function of heart, liver and kidney. No matter how high the dose is, it is impossible to completely kill leukemia cells in the body. Residual leukemia cells are always the root of disease recurrence

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0009] The composition is: V A 10 mg, V E 100mg, V D3 0.5mg, V B1 60mg, V B2 30mg, V B6 60mg, Niacin 50mg, V C 300mg, biotin 0.9mg, pantothenic acid 60mg, folic acid 15mg, V B12 0.5mg, zinc 15mg, iron 2mg, troxerutin 120mg, rutin 10mg, aspirin 0mg.

[0010] How to take it: Take it three times a day.

Embodiment 2

[0012] The composition is: V A 0.9 mg, V E 200mg, V D3 0.75mg, V B1 45 mg, V B2 20mg, V B6 45mg, Niacin 150mg, V C 200mg, biotin 0.6mg, pantothenic acid 40mg, folic acid 0.7mg, V B12 0.3mg, zinc 12mg, iron 3mg, troxerutin 240mg, rutin 25mg, aspirin 300mg.

[0013] How to take it: Take it three times a day.

Embodiment 3

[0015] The composition is: V A 0.7 mg, V E 300mg, V D3 1 mg, V B1 30mg, V B2 10 mg, V B6 30mg, Niacin 300mg, V C 100mg, biotin 0.3mg, pantothenic acid 25mg, folic acid 5mg, V B12 0.125mg, zinc 10mg, iron 4mg, troxerudin 360mg, rutin 40mg, aspirin 600mg.

[0016] How to take it: Take it three times a day.

[0017] Explanation: The prescriptions of the above three examples belong to the three treatment stages of moderate and severe patients. Example 1 is suitable for the first stage for about 5-7 days, Example 2 belongs to the second stage, and Example 3 belongs to the third stage . The prescription of the whole course of treatment should be relatively dynamic and change with the recovery of hematopoietic function, mainly due to the body’s response to V E The adaptability of , troxalutin, and aspirin is generally increased, and the dosage of niacin is also increased with the improvement of the disease, and the others are reduced with the improvement of the body and...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a medicament for treating leukemia comprising components as follows, whose weight unit is mg, VA 5-10mg, VE 100-300mg, VD3 0.5-1mg, VB1 30-60mg, VB2 10-30mg, VB6 30-60mg , nicotinic acid 50-300mg, VC 100-300mg, biotin 0.3-0.9mg, pantothenic acid 25-60mg, folic acid 5-15mg, VB12 0.125-0.5mg, zinc 10-15mg, ferrum 2-4mg, troxerutin 120-360mg, birutan 10-40mg and aspirin 0-600mg. The invention receives the theory of the traditional Chinese and western medicine, which is made from seventeen medicaments selected carefully and composed scientifically. The invention indicates a radical approach for treating cancer completely and provides the medicament with a high healing and small side effects in which treatment of cancer and alimentology are associated perfectly.

Description

technical field [0001] The invention relates to a medicine for treating leukemia. Background technique [0002] Leukemia is a malignant disease of the hematopoietic system, commonly known as "blood cancer", and is one of the top ten high-incidence malignant tumors in China. Cells) progressive and uncontrolled abnormal proliferation in bone marrow or other hematopoietic tissues, infiltrate and damage various tissues, and produce different symptoms. Clinical manifestations are characterized by fever, hemorrhage, anemia, enlargement of liver, spleen, and lymph nodes. Leukemia is generally divided into acute and chronic according to the natural course of the disease and the degree of immaturity of the cells. According to the cell type, it is divided into granulocytes, lymphocytes, monocytes and other types. The clinical manifestations are different. In recent years, with the development of medical technology, methods such as chemotherapy and radiotherapy can be used to curb di...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K33/30A61P35/02A61K33/24A61K31/714A61K31/616A61K31/593A61K31/519A61K31/525A61K31/51A61K31/455A61K31/4415A61K31/4188A61K31/352A61K31/197
Inventor 时竹明
Owner 时竹明
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products